STOCK TITAN

Imax Corp (IMAX) Financials

IMAX
Trailing 12 months to June 30, 2026
Revenue $416.1M +14.8% YoY
Net Income $40.9M +24.7% YoY
EPS (Diluted) $0.72 +22.0% YoY
Free Cash Flow $126.6M +88.4% YoY
Market Cap $2.9B as of Oct 3, 2026
Price / Sales 6.9x on $416.1M revenue, trailing 12 months to June 30, 2026
Price / Earnings 70.6x on $40.9M net income, trailing 12 months to June 30, 2026
Price / Book 8.1x on $355.9M equity, Q2 FY2026

A multiple compares the market's price with a filed figure; it says what the market pays, not how the business is doing. The market capitalization is the vendor's as of Oct 3, 2026; every other figure is from the SEC filings on this page. Not financial advice.

Source SEC Filings (10-K/10-Q) Latest period Q2 FY2026, ended Jun 30, 2026 Reported Currency USD FYE December

Newest figures come from the 10-Q for Q2 FY2026, filed Jul 23, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the IMAX SEC filings page.

Imax Corp (IMAX) reported $416.1M in revenue over the twelve months to Jun 30, 2026, up 14.8% from the prior twelve months. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 15 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI IMAX FY2025

IMAX’s 2025 rebound turned stronger sales into disproportionately more cash, with operating costs absorbing less of each added dollar.

Revenue increased from $375M in FY2023 to $410M in FY2025, while free-cash-flow margin more than doubled over the same span, showing the recovery became more cash-generative rather than merely larger. By FY2025, operating cash flow exceeded net income by a wide margin, so cash conversion was running ahead of reported earnings rather than being consumed by reinvestment.

Gross margin widened from 54.0% to 60.0% between FY2024 and FY2025, so the latest sales mix or unit economics left more contribution after direct costs. Operating margin reached 20.5%, showing fixed operating costs absorbed less of incremental sales as gross profit expanded.

FY2025 free cash flow was $119M against $8M of capital expenditures, implying a light reinvestment model relative to the cash generated. Liabilities stood at $466M and debt-to-equity at 1.4x, so liability funding remains material even as equity improved.

[ NOT FINANCIAL ADVICE ]

Financial Health Signals

Profitability Growth Leverage Liquidity CashFlow Returns 41 / 100
Financial Health Score 41/100

Scored against operating companies for FY2025. Each of the six dimensions is a percentile rank within that peer group; the overall is their average, with missing dimensions counted as zero out of six. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →

Health score ≠ stock price. This rates the quality of Imax Corp's business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.

Profitability
70

Imax Corp has an operating margin of 20.5%, meaning the company retains $21 of operating profit per $100 of revenue. This strong profitability earns a score of 70/100, reflecting efficient cost management and pricing power. This is up from 12.4% the prior year.

Growth
48

Imax Corp's revenue surged 16.5% year-over-year to $410.2M, reflecting rapid business expansion. This strong growth earns a score of 48/100.

Leverage
40

Imax Corp has a moderate D/E ratio of 1.38. This balance of debt and equity financing earns a leverage score of 40/100.

Liquidity
0

Not available for Imax Corp, and counted as zero in the overall score.

Cash Flow
89

Imax Corp converts 29.0% of revenue into free cash flow ($118.9M). This strong cash generation earns a score of 89/100.

Returns
0

Not available for Imax Corp, and counted as zero in the overall score.

Piotroski F-Score Partial
6/7

Imax Corp passes 6 of 7 computable financial strength tests (2 of the nine could not be computed from available data). All 4 profitability signals pass (positive income, cash flow, and earnings quality), no leverage/liquidity signals pass (rising debt, declining liquidity, or share dilution), both operating efficiency signals pass.

Earnings Quality Cash-Backed
3.64x

For every $1 of reported earnings, Imax Corp generates $3.64 in operating cash flow ($127.1M OCF vs $34.9M net income). This indicates profits are well-supported by actual cash generation, not accounting adjustments.

Interest Coverage Safe
11.44x

Imax Corp earns $11.44 in operating income for every $1 of interest expense ($84.2M vs $7.4M). This wide margin provides strong safety for debt servicing, even if earnings decline temporarily.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue
$102.8M
YoY+12.2%
QoQ+26.4%
5Y CAGR+15.1%
10Y CAGR+1.1%

Imax Corp generated $102.8M in revenue in Q2 2026. This represents an increase of 12.2% from the same quarter a year earlier. Against the prior quarter it is up 26.4%.

EBITDA
$36.4M
YoY+20.5%
QoQ+44.7%
5Y CAGR+29.4%

Imax Corp's EBITDA was $36.4M in Q2 2026, measuring earnings before interest, taxes, depreciation, and amortization. This represents an increase of 20.5% from the same quarter a year earlier. Against the prior quarter it is up 44.7%.

Net Income
$15.4M
YoY+36.8%
QoQ+264.5%
10Y CAGR+9.9%

Imax Corp reported $15.4M in net income in Q2 2026. This represents an increase of 36.8% from the same quarter a year earlier. Against the prior quarter it is up 264.5%.

EPS (Diluted)
$0.27
YoY+35.0%
QoQ+285.7%

Imax Corp earned $0.27 per diluted share (EPS) in Q2 2026. This represents an increase of 35.0% from the same quarter a year earlier. Against the prior quarter it is up 285.7%.

Cash & Balance Sheet

Free Cash Flow
$32.0M
YoY+53.2%
QoQ+1585.0%
10Y CAGR+1.6%

Imax Corp generated $32.0M in free cash flow in Q2 2026, representing cash available after capex. This represents an increase of 53.2% from the same quarter a year earlier. Against the prior quarter it is up 1585.0%.

Cash & Debt
$159.9M
YoY+46.4%
QoQ+9.5%
5Y CAGR-5.7%
10Y CAGR-3.5%

Imax Corp held $159.9M in cash as of Q2 2026; long-term debt is not reported for that period.

Shares Outstanding
55M
YoY+2.0%
QoQ0.0%
5Y CAGR-1.6%
10Y CAGR-2.0%

Imax Corp had 55M shares outstanding in Q2 2026. This represents an increase of 2.0% from the same quarter a year earlier. It is unchanged from the prior quarter.

Dividends Per Share

Not reported for Q2 2026.

Margins & Returns

Gross Margin
61.2%
YoY+2.7pp
QoQ+4.9pp
5Y change+10.9pp
10Y change+6.4pp

Imax Corp's gross margin was 61.2% in Q2 2026, indicating the percentage of revenue retained after direct costs. This is up 2.7 percentage points from the same quarter a year earlier. Against the prior quarter it is up 4.9 percentage points.

Operating Margin
20.2%
YoY+4.6pp
QoQ+8.0pp
5Y change+26.0pp

Imax Corp's operating margin was 20.2% in Q2 2026, reflecting core business profitability. This is up 4.6 percentage points from the same quarter a year earlier. Against the prior quarter it is up 8.0 percentage points.

Net Margin
15.0%
YoY+2.7pp
QoQ+9.8pp
5Y change+33.1pp
10Y change+8.4pp

Imax Corp's net profit margin was 15.0% in Q2 2026, showing the share of revenue converted to profit. This is up 2.7 percentage points from the same quarter a year earlier. Against the prior quarter it is up 9.8 percentage points.

Return on Equity
4.3%
YoY+0.8pp
QoQ+3.1pp
5Y change+7.0pp
10Y change+3.3pp

Imax Corp's ROE was 4.3% in Q2 2026, measuring profit generated per dollar of shareholder equity. This is up 0.8 percentage points from the same quarter a year earlier. Against the prior quarter it is up 3.1 percentage points.

Capital Allocation

R&D Spending
$1.7M
YoY+7.3%
QoQ-8.3%

Imax Corp invested $1.7M in research and development in Q2 2026. This represents an increase of 7.3% from the same quarter a year earlier. Against the prior quarter it is down 8.3%.

Capital Expenditures
$21K
YoY-99.1%
QoQ-99.0%
5Y CAGR-52.8%
10Y CAGR-40.7%

Imax Corp invested $21K in capex in Q2 2026, funding long-term assets and infrastructure. This represents a decrease of 99.1% from the same quarter a year earlier. Against the prior quarter it is down 99.0%.

Share Buybacks

Not reported for Q2 2026.

IMAX Income Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

IMAX quarterly income statement
MetricQ2'2610-QQ1'2610-QQ4'2510-QQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-KQ3'2410-Q
Revenue$102.8M+12.2%$81.4M-6.1%$125.2M+35.1%$106.7M+16.6%$91.7M+3.1%$86.7M+9.5%$92.7M+7.7%$91.5M-12.0%
Cost of Revenue$39.9M+4.9%$35.6M+6.2%$53.1M+19.8%$39.4M-2.6%$38.1M-15.4%$33.5M+3.9%$44.3M+4.7%$40.4M-1.8%
Gross Profit$62.9M+17.3%$45.8M-13.9%$72.1M+49.2%$67.3M+31.9%$53.6M+22.0%$53.2M+13.4%$48.4M+10.7%$51.0M-18.6%
R&D Expenses$1.7M+7.3%$1.8M+36.9%$1.5M$1.5M$1.5M-24.1%$1.3M-39.7%N/AN/A
SG&A Expenses$34.5M-2.2%$32.5M-2.9%$35.5M+9.4%$34.2M+8.7%$35.3M-6.0%$33.5M+7.1%$32.4M-7.6%$31.5M-13.3%
Operating Income$20.8M+44.8%$10.0M-40.5%$24.1M+153.4%$29.0M+49.6%$14.3M+399.5%$16.7M+38.7%$9.5M+247.3%$19.4M-11.9%
EBITDA$36.4M+20.5%$25.2M-20.4%$40.1M+53.7%$44.7M+30.1%$30.2M+39.3%$31.6M+16.2%$26.1M+60.4%$34.3M-16.9%
Interest Expense$2.0M+1.8%$1.9M+5.3%$1.8M+11.4%$1.8M-18.2%$1.9M-15.6%$1.8M-7.4%$1.6M-9.0%$2.2M+51.0%
Income Tax$3.5M+192.7%$2.4M-66.8%$4.1M+179.8%$5.2M+119.1%$1.2M+130.0%$7.3M+41.2%$1.5M+178.8%$2.4M-63.8%
Net Income$15.4M+36.8%$4.2M+81.6%$661K-87.6%$20.7M+48.7%$11.3M+214.1%$2.3M-28.9%$5.3M+113.5%$13.9M+15.9%
EPS (Basic)$0.28+33.3%$0.08+100.0%$0.01-90.0%$0.38+46.2%$0.21+200.0%$0.04-33.3%$0.10+100.0%$0.26+18.2%
EPS (Diluted)$0.27+35.0%$0.07+75.0%$0.01-88.9%$0.37+42.3%$0.20+185.7%$0.04-33.3%$0.09+80.0%$0.26+18.2%
Diluted Shares (Avg)57M+2.6%56M+2.6%N/A56M+2.7%55M+3.2%55M+2.9%N/A54M-2.6%

IMAX Balance Sheet

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

IMAX quarterly balance sheet
MetricQ2'2610-QQ1'2610-QQ4'2510-QQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-KQ3'2410-Q
Total Assets$917.9M+5.7%$893.2M+5.3%$894.0M+7.7%$889.6M+5.0%$868.6M+5.0%$848.3M+2.9%$830.4M+1.9%$847.6M-0.4%
Cash & Equivalents$159.9M+46.4%$146.0M+50.4%$151.2M+50.3%$143.1M+36.9%$109.3M+19.3%$97.1M+19.8%$100.6M+32.0%$104.5M-4.7%
Short-Term Investments$0$0$0$0$0$0$0$0
Inventory$39.2M+6.9%$35.8M+12.9%$32.5M-1.0%$41.4M+10.2%$36.7M-2.9%$31.7M-12.2%$32.8M+4.0%$37.6M-17.1%
Accounts Receivable$114.6M-9.8%$108.5M-11.3%$108.1M+0.4%$108.4M-5.1%$126.9M+4.5%$122.3M-13.0%$107.7M-21.0%$114.2M-16.0%
Long-Term Investments$0$0$0$0$0$0$0$0
Goodwill$45.8M-13.3%$45.8M-13.3%$45.8M-13.3%$52.8M0.0%$52.8M0.0%$52.8M0.0%$52.8M0.0%$52.8M0.0%
Total Liabilities$467.5M+0.9%$464.8M+0.2%$466.3M+3.1%$452.9M-5.6%$463.5M-4.3%$464.0M-5.4%$452.2M-3.6%$479.8M-2.8%
Total Equity$355.9M+11.1%$335.5M+12.0%$337.9M+12.8%$349.5M+20.8%$320.4M+19.9%$299.5M+15.7%$299.5M+9.6%$289.4M+0.8%
Retained Earnings-$230.8M+11.7%-$235.7M+13.5%-$240.0M+12.6%-$240.6M+14.1%-$261.3M+11.1%-$272.4M+8.4%-$274.7M+6.2%-$280.0M-2.8%

Not reported in any period shown, so not listed: Current Assets, Current Liabilities, Non-Current Liabilities, Long-Term Debt.

IMAX Cash Flow Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

IMAX quarterly cash flow statement
MetricQ2'2610-QQ1'2610-QQ4'2510-QQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-KQ3'2410-Q
Operating Cash Flow$32.0M+37.7%$4.0M-42.0%$29.4M+155.8%$67.5M+91.4%$23.2M-33.7%$7.0M+163.4%$11.5M+186.6%$35.3M+22.7%
Depreciation & Amortization$15.7M-1.4%$15.2M+2.2%$16.0M-3.4%$15.6M+4.7%$15.9M-15.6%$14.9M-1.7%$16.6M+22.6%$14.9M-22.7%
Stock-Based Compensation$7.3M-1.4%$5.7M+9.6%N/A$6.3M+16.7%$7.4M+7.2%$5.2M+10.6%N/A$5.4M+3.8%
Capital Expenditures$21K-99.1%$2.1M+29.6%$1.4M-69.3%$2.7M+143.7%$2.4M+48.9%$1.6M+49.0%$4.6M+16.8%$1.1M-26.5%
Free Cash Flow$32.0M+53.2%$1.9M-64.2%$28.0M+306.8%$64.8M+89.6%$20.9M-37.6%$5.3M+144.0%$6.9M+11957.9%$34.2M+25.5%
Investing Cash Flow-$6.1M+17.8%-$6.9M+52.6%-$7.1M+34.3%-$12.7M+13.4%-$7.4M+12.6%-$14.6M-104.8%-$10.9M+17.2%-$14.7M-45.0%
Financing Cash Flow-$11.5M-206.7%-$2.8M-165.2%-$13.7M-169.1%-$20.9M-175.9%-$3.8M+76.8%$4.2M-81.4%-$5.1M+79.0%-$7.6M-64.8%
Share BuybacksN/AN/AN/AN/AN/A$0-100.0%N/A$0-100.0%

Not reported in any period shown, so not listed: Dividends Paid.

IMAX Financial Ratios

Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

IMAX quarterly financial ratios
MetricQ2'2610-QQ1'2610-QQ4'2510-QQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-KQ3'2410-Q
Gross Margin61.2%+2.7pp56.3%-5.1pp57.6%+5.4pp63.1%+7.3pp58.5%+9.1pp61.4%+2.1pp52.2%+1.4pp55.8%-4.6pp
Operating Margin20.2%+4.6pp12.2%-7.1pp19.3%+9.0pp27.2%+6.0pp15.7%+12.4pp19.3%+4.1pp10.3%+7.1pp21.2%0.0pp
Net Margin15.0%+2.7pp5.2%+2.5pp0.5%-5.2pp19.4%+4.2pp12.3%+8.3pp2.7%-1.5pp5.8%+2.9pp15.2%+3.7pp
Return on Equity4.3%+0.8pp1.3%+0.5pp0.2%-1.6pp5.9%+1.1pp3.5%+2.2pp0.8%-0.5pp1.8%+0.9pp4.8%+0.6pp
Return on Assets1.7%+0.4pp0.5%+0.2pp0.1%-0.6pp2.3%+0.7pp1.3%+0.9pp0.3%-0.1pp0.6%+0.3pp1.6%+0.2pp
Debt-to-Equity1.31-0.1x1.39-0.2x1.38-0.1x1.30-0.4x1.45-0.4x1.55-0.3x1.51-0.2x1.66-0.1x
Asset Turnover0.110.0x0.090.0x0.140.0x0.120.0x0.110.0x0.100.0x0.110.0x0.110.0x
FCF Margin31.1%+8.3pp2.3%-3.8pp22.3%+14.9pp60.7%+23.4pp22.8%-14.8pp6.1%+21.4pp7.4%+7.3pp37.4%+11.1pp

Not reported in any period shown, so not listed: Current Ratio.

Similar Companies

Newest fiscal year on record for each company. The health score is the peer-relative Financial Health Score for that year; a dash means no score is published for it.

Company Fiscal year Revenue Net income Net margin Market cap Health score
Imax Corp IMAX FY2025 $410.2M $34.9M 8.5% $2.9B 41/100
AMC ENTERTAINMENT HOLDINGS, INC. AMC FY2025 $4.8B -$632.4M -13.0% $2.5B 19/100
Sphere Entertainment Co. SPHR FY2025 $1.2B $33.4M 2.7% $4.6B 34/100
Dave & Buster's Entertainment, Inc. PLAY FY2025 $2.1B -$48.7M -2.3% $235.1M 28/100
HUYA Inc. HUYA FY2025 $929.8M -$16.1M -1.7% $525.2M 41/100
Reservoir Media, Inc. RSVR FY2026 $175.7M $7.8M 4.5% $627.7M 58/100

Frequently Asked Questions

What is Imax Corp's annual revenue?

Imax Corp (IMAX) reported $410.2M in total revenue for fiscal year 2025. This represents a 16.5% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

How fast is Imax Corp's revenue growing?

Imax Corp (IMAX) revenue grew by 16.5% year-over-year, from $352.2M to $410.2M in fiscal year 2025.

Is Imax Corp profitable?

Yes, Imax Corp (IMAX) reported a net income of $34.9M in fiscal year 2025, with a net profit margin of 8.5%.

Imax Corp (IMAX) reported diluted earnings per share of $0.63 for fiscal year 2025. This represents a 31.3% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

Imax Corp (IMAX) had EBITDA of $146.7M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.

Imax Corp (IMAX) had a gross margin of 60.0% in fiscal year 2025, indicating the percentage of revenue retained after direct costs of goods sold.

Imax Corp (IMAX) had an operating margin of 20.5% in fiscal year 2025, reflecting the profitability of core business operations before interest and taxes.

Imax Corp (IMAX) had a net profit margin of 8.5% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.

Imax Corp (IMAX) has a return on equity of 10.3% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.

Imax Corp (IMAX) generated $118.9M in free cash flow during fiscal year 2025. This represents a 90.5% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.

Imax Corp (IMAX) generated $127.1M in operating cash flow during fiscal year 2025, representing cash generated from core business activities.

Imax Corp (IMAX) had $894.0M in total assets as of fiscal year 2025, including both current and long-term assets.

Imax Corp (IMAX) invested $8.2M in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.

Imax Corp (IMAX) invested $5.8M in research and development during fiscal year 2025.

Imax Corp (IMAX) had 54M shares outstanding as of fiscal year 2025.

Imax Corp (IMAX) had a debt-to-equity ratio of 1.38 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.

Imax Corp (IMAX) had a return on assets of 3.9% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

Imax Corp (IMAX) trades at 70.6x earnings, its market capitalization divided by net income of $40.9M net income, trailing 12 months to June 30, 2026. The market capitalization is $2.9B as of Oct 3, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.

Imax Corp (IMAX) trades at 6.9x sales, its market capitalization divided by revenue of $416.1M revenue, trailing 12 months to June 30, 2026. The market capitalization is $2.9B as of Oct 3, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.

Imax Corp (IMAX) has a Piotroski F-Score of 6 out of 7 computable signals; 2 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Imax Corp (IMAX) has an earnings quality ratio of 3.64x, considered cash-backed (high quality). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

Imax Corp (IMAX) has an interest coverage ratio of 11.44x, meaning it can comfortably cover its interest obligations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.

Imax Corp (IMAX) scores 41 out of 100 on our Financial Health Score, indicating moderate standing within its operating companies peer group. The score is a 0-100 composite of six dimensions (Profitability, Growth, Leverage, Liquidity, Cash Flow, Returns), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.

Back to top